Which anticholinergic medication is commonly used as a bronchodilator in asthma?

Which anticholinergic medication is commonly used as a bronchodilator in asthma?

• A. Atropine
• B. Ipratropium
• C. Glycopyrrolate
• D. Scopolamine

Answer: (B)

Ipratropium is commonly used as a bronchodilator in asthma due to its specific mechanism of action as an anticholinergic agent. It works by blocking the activity of acetylcholine on muscarinic receptors in the airway smooth muscles, leading to relaxation and dilation of the bronchial passages. This results in improved airflow and alleviation of respiratory symptoms associated with asthma. Ipratropium is often administered via inhalation, which allows for localized effects in the lungs with minimal systemic absorption, making it effective for management of asthma exacerbations and chronic respiratory conditions like chronic obstructive pulmonary disease (COPD). It's particularly beneficial for patients who may have sensitivity to β-agonists or require additional bronchodilation alongside other treatments. Other anticholinergic medications listed, such as atropine, glycopyrrolate, and scopolamine, do not primarily serve as bronchodilators in the context of asthma management. Atropine is more commonly used in other medical settings, glycopyrrolate is often used to reduce saliva production and manage drooling, and scopolamine primarily serves to prevent nausea and motion sickness. Thus, while they have anticholinergic properties, they do not fulfil the role of bron

Ipratropium is commonly used as a bronchodilator in asthma due to its specific mechanism of action as an anticholinergic agent. It works by blocking the activity of acetylcholine on muscarinic receptors in the airway smooth muscles, leading to relaxation and dilation of the bronchial passages. This results in improved airflow and alleviation of respiratory symptoms associated with asthma.

Ipratropium is often administered via inhalation, which allows for localized effects in the lungs with minimal systemic absorption, making it effective for management of asthma exacerbations and chronic respiratory conditions like chronic obstructive pulmonary disease (COPD). It's particularly beneficial for patients who may have sensitivity to β-agonists or require additional bronchodilation alongside other treatments.

Other anticholinergic medications listed, such as atropine, glycopyrrolate, and scopolamine, do not primarily serve as bronchodilators in the context of asthma management. Atropine is more commonly used in other medical settings, glycopyrrolate is often used to reduce saliva production and manage drooling, and scopolamine primarily serves to prevent nausea and motion sickness. Thus, while they have anticholinergic properties, they do not fulfil the role of bron